Rifetech® technology emits electromagnetic waves in Hz and kHz, with a maximum of 900 kHz. This wave range has the experimental potential to act on pathogenic microorganisms such as viruses, bacteria, fungi, protozoa, and invertebrates - flat and roundworms and mites. It is possible to trace the connection between the complexity of the organism and the frequency band in which its cells begin to resonate. More detailed information - the basis of this experimental methodology - can be found, for example, in the literature of Dr. Hulda Clarke, who reached her conclusions about the connections between pathogenic microorganisms and specific frequency bands in the laboratory. 

The biophysical and biochemical properties of genomic materials can be used to determine resonance compensation frequencies. For example, the length of any object can be considered an object with a resonance frequency based on correlation with the wavelength manifested in the surrounding medium. On this basis, it is possible to calculate the length of the biomolecular chains of DNA and RNA, and in doing so obtain information about the concordance of the wavelength with the wavelength unique to a particular strand of genomic material. DNA or RNA chains are constructed in such a way that negatively-charged molecular ions (PO, groups) are helical along the entire length of the molecule on the outer surface of the chain, causing the molecule to contain a relatively large negative charge on its surface. The chain is therefore highly sensitive to the effects of the resonant oscillating electromagnetic fields generated by Rifetech® technology.

Using genetic coding information, methods for determining resonance compensation frequencies can also be used for other subcomponents of genomic material, such as coding associated with enzymes, immunological factors, oncogenes, oncogenic growth factors, and other proteins. 

The results of research in the field of influencing biological systems using electromagnetic fields at biomolecular level show that, under certain circumstances, external pulses can induce oscillations of microtubules forming a mitotic spindle, in the vicinity of which a local high-frequency electric field with variable spatial structure and high intensity is subsequently generated, which can disrupt the course of mitosis. The research will primarily be used in medicine, where short electrical pulses are beginning to be seen as a promising method for the treatment of tumours. The action of a specifically-tuned electric field to treat glioblastoma is a patented method. The mechanism of effect of the electric field lies in the impact on the electrically-charged parts of cells and thus prevents the normal course of mitosis, which leads to the death of cancer cells. Frequency bands with the potential to stop mitosis of cancer cells draw on a study conducted at Na Homolce Hospital in Prague. This study looked for frequencies that inhibit mitosis by acting, probably, on the microtubules of cancer cells, which is their "Achilles heel". While different types of tumours are affected by different frequencies, it was found that most of them lie within the 100 kHz-300 kHz band. The study also shows that a frequency of 100 kHz works universally.

Do you want to cooperate?

Are you interested in our research and development in the sphere of the medical potential of pulsed EM fields and plasma and would like to integrate our technology with your professional therapeutic, rehabilitation, or medical practice? Are you interested in opening up new markets with us, markets that our technology has not yet broken through to? Or would you like to use the background of our expert development team to customize our technology to the specific requirements of your professional practice or client network?

 Then contact us!